ISSN 1673-3770 CN 37-1437/R
山东大学耳鼻喉眼学报 ›› 2017, Vol. 31 ›› Issue (6): 16-20.doi: 10.6040/j.issn.1673-3770.1.2017.040
• 甲状腺癌的规范化诊断与治疗·专题笔谈 • 上一篇 下一篇
孙滨,郭伯敏,康杰,邓先兆,伍波,樊友本
SUN Bin, GUO Bomin, KANG Jie, DENG Xianzhao, WU Bo, FAN Youben
摘要： 甲状腺未分化癌是恶性程度最高的甲状腺肿瘤,侵袭性高,转移早,预后极差。目前临床上采用手术、放疗、化疗及靶向治疗等方式进行综合治疗,但尚未有十分有效的规范化治疗方案,结合该院诊治经验,探索甲状腺未分化癌的规范化治疗。
中图分类号:
| [1] Kebebew E, Greenspan FS, Clark OH, et al. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors[J]. Cancer, 2005,103(7):1330-1335. [2] Wendler J, Kroiss M, Gast K, et al. Clinical presentation, treatment and outcome of anaplastic thyroid carcinoma: results of a multicenter study in germany[J]. Eur J Endocrinol, 2016, 175(6):521-529. [3] Segerhammar I, Larsson C, Nilsson IL, et al. Anaplastic carcinoma of the thyroid gland: treatment and outcome over 13 years at one institution[J]. J Surg Oncol, 2012, 106(8):981-986. [4] Smallridge RC, Ain KB, Asa SL, et al. American thyroid association guidelines for management of patients with anaplastic thyroid cancer[J]. Thyroid, 2012, 22(11):1104-1139. [5] Haddad RI, Lydiatt WM, Ball DW, et al. Anaplastic thyroid carcinoma, version 2.2015[J]. J Natl Compr Canc Netw, 2015, 13(9):1140-1150. [6] Zivaljevic V, Tausanovic K, Paunovic I, et al. Age as a prognostic factor in anaplastic thyroid cancer[J]. Int J Endocrinol, 2014: 240513. [7] Akaishi J, Sugino K, Kitagawa W, et al. Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma[J]. Thyroid, 2011, 21(11):1183-1189. [8] Sugitani I, Miyauchi A, Sugino K, et al. Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: Atc research consortium of japan cohort study of 677 patients[J]. World J Surg, 2012, 36(6):1247-1254. [9] Yoshida A, Matuzu K. Analysis of long-term survivors in anaplastic thyroid carcinoma[J]. Nihon Geka Gakkai Zasshi, 2012, 113(4):373-377. [10] Sugitani I, Hasegawa Y, Sugasawa M, et al. Super-radical surgery for anaplastic thyroid carcinoma: a large cohort study using the anaplastic thyroid carcinoma research consortium of japan database[J]. Head Neck, 2014, 36(3):328-333. [11] 张宗敏, 徐震纲, 唐平章, 等. 重新认识甲状腺未分化癌[J]. 中国医学科学院学报, 2006,28(3):322-324. ZHANG Zongmin, XU Zhengang, TANG Pingzhang, et al. A retrospective analysis of anaplastic thyroid carcinoma[J]. Act Acad Med Sin, 2006, 28(3):322-324. [12] Pierie JP, Muzikansky A, Gaz RD, et al. The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma[J]. Ann Surg Oncol, 2002, 9(1):57-64. [13] Sun C, Li Q, Hu Z, et al. Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in china[J]. PloS one, 2013, 8(11):80011. [14] Sherman EJ, Lim SH, Ho AL, et al. Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review[J]. Radiother Oncol, 2011, 101(3):425-430. [15] 房居高. 强化手术技能和规范诊疗是提高甲状腺癌疗效的根本[J]. 山东大学耳鼻喉眼学报,2016, 30(2):1-4. FANG Jugao. Operation skill and standard diagnosis and treatment are the basics of improving the curative effect of thyroid carcinoma[J]. J Otolaryngol Ophthal Shandong Univ, 2016, 30(2):1-4. [16] Zhou M, Chen Y, Adachi M, et al. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer[J]. Biomaterials, 2015, 57:41-49. [17] Bhatia A, Rao A, Ang KK, et al. Anaplastic thyroid cancer: clinical outcomes with conformal radiotherapy[J]. Head Neck, 2010, 32(7):829-836. [18] Lowe NM, Loughran S, Slevin NJ, et al. Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival-a single centre experience and review of the literature[J]. Sci World J, 2014: 674583. [19] Seto A, Sugitani I, Toda K, et al. Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases[J]. Surg Today, 2015, 45(2):221-226. [20] Savvides P, Nagaiah G, Lavertu P, et al. Phase ii trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid[J]. Thyroid, 2013, 23(5):600-604. [21] Wein RO, Weber RS. Anaplastic thyroid carcinoma: Palliation or treatment?[J]. Curr Opin Otolaryngol Head Neck Surg, 2011, 19(2):113-118. [22] Pennell NA, Daniels GH, Haddad RI, et al. A phase ii study of gefitinib in patients with advanced thyroid cancer[J]. Thyroid, 2008, 18(3):317-323. |
| [1] | 方璐, 雷玉丹, 王华. 环孢素滴眼液联合玻璃酸钠滴眼液治疗干眼临床效果的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 65-73. |
| [2] | 雷玉丹,方璐,陈健,彭昌福. 托珠单抗治疗激素抵抗或不耐受的中重度甲状腺相关性眼病临床疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 54-67. |
| [3] | 朱明琼,李征,刘茹,田涛,彭婧利,吕倩怡,谭华霞. 基于OCT/OCTA的AI筛查系统在抗VEGF治疗糖尿病性黄斑水肿患者效果评价中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 68-73. |
| [4] | 卢朝阳, 翟兆雪, 王慧康, 邵丽婷, 张宇. 新冠肺炎治疗引发糖尿病酮症酸中毒合并鼻眶脑型毛霉菌病1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 90-94. |
| [5] | 顾敏,陆美萍. 纳米药物输送系统在变应性鼻炎过敏原免疫治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 106-111. |
| [6] | 刘一洁,卢秀珍,吴秋欣. 外泌体在眼病发病机制和诊疗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 135-141. |
| [7] | 刘玉柱,陈尧,苑铁君,李春森,李波. 喉纤维肉瘤1例并相关文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 133-137. |
| [8] | 韩鑫宇,陈钢钢,李莹,周丽媛,杨捷,吴佳鑫,李育军. 双侧前庭病的非药物治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 154-159. |
| [9] | 王晓杰,张明君,宋哲莹,崔丽梅,宋西成. 山奈酚抗癌的作用机制及研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 168-178. |
| [10] | 许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33. |
| [11] | 黄旗,邓旭雯,王佩佩,陈烨群,古学军. 基于EyeSi手术模拟器评估眼科医师白内障手术水平[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 83-88. |
| [12] | 刘玉柱,苑铁君,李波. 会厌原发神经内分泌癌1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 97-100. |
| [13] | 张婷,王美兰,高映勤. 白细胞介素35在变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 139-147. |
| [14] | 邱前辉,肖旭平,杨钦泰,叶菁,邓泽义,王德生,谭国林,蒋卫红,卢永田,唐隽,石照辉,邓晓聪,刘遗斌,王跃武,段传志,杜德坤,白小欣,陈文伙,莫立根,蔡楚伟,曾鹏,何旭英,杨一梅,赵洲洋,陈健龙,赵充,林志雄,李先明,李曙平,陈冬平,陈勇,黄莹,陈春燕,韩非,黄理金,瞿申红. 鼻咽癌治疗后并发颈动脉爆裂综合征的临床处理专家共识[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 1-18. |
| [15] | 朱瑞楷,吴家荣,孙芳,谢楚波,邱前辉. 基于计算机断层扫描血管造影术评估鼻咽癌放疗后引起颈内动脉狭窄状况及其影响因素的研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 77-84. |
|
||